Home › Free Stock Grades › TLSI
TriSalus Life Sciences, Inc. (TLSI) Stock Grade
TLSI · Healthcare
A+
Market Cap
$343.4M
P/E Ratio
—
Revenue Growth (YoY)
+53.4%
Net Margin
-86.9%
Return on Equity
115.8%
Dividend Yield
None
About TriSalus Life Sciences, Inc.'s fundamentals
TriSalus Life Sciences is a medical device company with a market capitalization of $343.4 million that is experiencing strong revenue growth of 53.4% year-over-year, indicating expanding sales activity. However, the company is currently unprofitable with a net margin of -86.9% and reported a net loss in its latest annual statement, meaning it is spending significantly more than it generates in revenue. The company does not pay a dividend, which is typical for growth-stage medical device firms that reinvest losses and capital into operations.